Talis Biomedical Stock

Talis Biomedical Net Margin

Delisted

The Net Profit Margin of Talis Biomedical (TLIS) as of Aug 1, 2026 is -2,905.67 %. In the previous year, Net Profit Margin was -2,348.55 % — a change of 23.72% (lower).

Net Margin

-2,905.67 %

YoY

23.72%

Last updated:

Net Profit Margin of Talis Biomedical is 2026 -2,905.67 % . Net Profit Margin of Talis Biomedical was 2025 -2,348.55 % . It decreases by 23.72% lower compared to the previous year.

For Talis Biomedical, the net margin of -2,905.7% is down versus 663.4% a few years ago.

Access this data via the Eulerpool API

Talis Biomedical Stock analysis

What does Talis Biomedical do? Talis Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Talis Biomedical stock

Net Profit Margin of Talis Biomedical is -2,905.67 % in 2026.

Access this data via the Eulerpool API

Margins — Talis Biomedical

All Key Metrics — Talis Biomedical